Direct Analysis of Plasma Fibrinogen-Derived Fibrinopeptides by High Performance Liquid Chromatography: Investigation of Aα-Chain N-Terminal Heterogeneity

Christopher Southan; Elizabeth Thompson; David A Lane

doi:10.1055/s-0038-1661638

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1986; 56(02): 193-197
DOI: 10.1055/s-0038-1661638

Original Article

Schattauer GmbH Stuttgart

Direct Analysis of Plasma Fibrinogen-Derived Fibrinopeptides by High Performance Liquid Chromatography: Investigation of Aα-Chain N-Terminal Heterogeneity

Christopher Southan

The Department of Haematology, Charing Cross and Westminster Medical School, Hammersmith, London, UK

,

Elizabeth Thompson

The Department of Haematology, Charing Cross and Westminster Medical School, Hammersmith, London, UK

,

David A Lane

The Department of Haematology, Charing Cross and Westminster Medical School, Hammersmith, London, UK

› Author Affiliations

Abstract

PDF Download

Summary

Fibrinopeptide A (FPA), released from the fibrinogen Aa-chain by thrombin, can be resolved by high-performance liquid chromatography (HPLC) into three forms, the intact peptide (A), a modified peptide phosphorylated at the serine in position 3 (AP), and an N-terminally degraded form (AY). A new method has been developed, using HPLC, that allows direct measurement of the proportions of AP, A, and AY released by thrombin from fibrinogen in plasma samples of 200 ul or less. The method was used to examine variations in the proportions of AP and AY expressed as a % of total FPA in a number of patient and control groups. The mean percentages of AP and AY of plasma fibrinogen were found to be 21.7 and 14.2%, respectively, in normal laboratory controls. In older, apparently normal, individuals these figures were 27.0 and 15.5%, respectively. Cord plasma exhibited very high AP and slightly reduced AY levels (41.6 and 12.4%, respectively) compared with normal adults. Patients with liver failure had low AP levels and high AY levels (11.6 and 21.1%, respectively). Patients, recovering from major surgery or acute thrombotic stroke showed an acute-phase rise in fibrinogen level that was accompanied by an increase in AP and variable reduction in AY. Incubation of heparinized whole blood for 8 days in vitro demonstrated a gradual decrease in the proportion of AP and increase in AY of plasma fibrinogen. These results provide some support for the idea that an increased “aging” of fibrinogen in the circulation may result in a decrease in the AP content of fibrinogen accompanied by a more variable increase in AY.

Keywords

Fibrinogen - Fibrinopeptides - HPLC

PDF (1076 kb)

References

References
1 Blombäck B, Blombäck M, Edman P, Hessel B. Human fibrinopep-tides, isolation, characterisation and structure. Biochim Biophys Acta 1966; 115: 371-396
2 Seydewitz HH, Kaiser C, Rotweiler H, Witt I. The location of a second in vivo phosphorylation site in the Aα-chain of human fibrinogen. Thromb Res 1984; 33: 489-498
3 Hanna L, Scheraga HA, Francis CW, Marder VJ. Comparison of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides. Biochemistry 1984; 23: 4681-4687
4 Shainoff JR, Dyment G, Hoffman GC, Merlin F. Fibrinopeptide composition in relation to age of fibrinogen. Circulation, LVI, Supplement II, abstract No 204 1972
5 Kehl M, Lottspeich F, Henschen A. Analysis of human fibrinopeptides by high performance liquid chromatography. Hoppe-Seyler’s Z Physiol Chem 1981; 362: 1661-1664
6 Southan C, Thompson E, Lane DA. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography. Thromb Res 1986; 43: 195-204
7 Southan C, Kehl M, Henschen A, Lane DA. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine → histidine substitution. Brit J Haematol 1983; 54: 143-151
8 Ebert RF, Bell WR. Assay of human fibrinopeptides by high performance liquid chromatography. Anal Biochem 1985; 148: 70-78
9 Southan C, Henschen A. The analysis of fibrinopeptide release from S-carboxymethylated fibrinogen chains using high performance liquid chromatography. In: Fibrinogen, Structural Variants and Interactions Henschen A, Hessel B, McDonagh J, Saldeen T. (Eds.) 73-82 Walter de Gruyter; Berlin - New York: 1985
10 Leeksma OC, Meijer Huizinga FM, Van Mourik JA. Fibrinopeptide A and the phosphorylation of fibrinogen. In: Fibrinogen, Fibrin Formation and Fibrinolysis Lane DA, Henschen A, Jasani K. (Eds) 23-31 Walter de Gruyter; Berlin - New York: 1986
11 Lane DA, Southan C, Ireland H, Thompson E, Kehl M, Henschen A. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the Aαl6Arg → His substitution upon fibrin monomer polymerisation and the immunological crossreactivity of the peptide. Brit J Haematol 1983; 53: 587-597
12 Galanakis DK, Martinez J, McDevitt C, Miller F. Human fetal fibrinogen. Annal NY Acad Sci 1983; 408: 640-643
13 Barnard DR, Simmons MA, Hatherway WE. Coagulation studies in extremely premature infants. Pediat Res 1979; 13: 1330-1335
14 Seydewitz HH, Witt I. Increased phosphorylation of human fibrinopeptide A under acute phase conditions. Thromb Res 1985; 40: 29-39
15 Teger-Nilsson AC. Degradation of human fibrinopeptides A and B in blood serum in vitro. Acta chem Scand 1968; 22: 3171-3182
16 Lane DA, Siodlak M, Thompson E, Allen-Mersh T. Clearance of human desaminotyrosyl fibrinopeptide A from the rat circulation: role of kidney and proteolytic enzymes. Thromb Res 1982; 26: 73-82
17 Southan C, Lane DA, Henschen A. Functional characterisation and protein chemical analysis of two new cases of dysfibrinogenaemia, London III and IV. In: Fibrinogen, Structure, Functional Aspects, Metabolism Haverkate F, Henschen A, Niewenhuizen W, Straub PW. (Eds) 167-182 Walter de Gruyter; Berlin - New York: 1983
18 Southan C, Lane DA. Screening small plasma samples by HPLC for abnormalities of fibrinopeptide release. In: Fibrinogen, Fibrin Formation and Fibrinolysis Lane DA, Henschen A, Jasani K. (Eds.) 103-110 Walter de Gruyter; Berlin - New York: 1986
19 Kaminski M, Carr M, McDonagh J. Quantitation of fibrinopeptides Ap and A as an indicator of fibrinogen turnover. Thromb Haemostas 1985 54. 1743 (Abstr)
20 Kudryk B, Okda M, Redman CM, Blombäck B. Biosynthesis of dog fibrinogen, characterisation of nascent fibrinogen in the rough endoplasmic reticulum. Eur J Biochem 1982; 125: 673-682
21 Lucas J, Kehl M, Henschen A. Fibrinopeptide characterisation and kinetics of release in animal fibrinogens as analysed by high performance liquid chromatography. In: Fibrinogen, Structure, Functional Aspects, Metabolism Haverkate F, Henschen A, Niewenhuisen W, Straub PW. (Eds) 59-69 Walter de Gruyter; Berlin - New York: 1983
22 Southan C, Lane DA, Knight I, Ireland H, Bottomley J. Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool. Biochem J 1985; 229: 723-730